Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
683 Capital Management, LLC WVE Wave Life Sciences, Inc. 13G/A 4.7% 2y
JANUS HENDERSON GROUP PLC IDYA IDEAYA Biosciences, Inc. 13G 5.5% 2y
Orbis Investment Management Limited BORR Borr Drilling Ltd 13G/A 8.8% 2y
Select Equity Group, L.P. ST Sensata Technologies Holding plc 13G/A 2.3% 2y
Divisadero Street Capital Management, LP TCMD Tactile Systems Technology Inc 13G/A 0.01% 2y
Redmile Group, LLC DCPH Deciphera Pharmaceuticals, Inc. Common Stock 13G/A 9.9% 2y
AMERIPRISE FINANCIAL INC VOYA Voya Financial, Inc. 13G/A 4.09% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC YOTA Yotta Acquisition Corp 13G 6.3% 2y
RA CAPITAL MANAGEMENT, L.P. TSHA Taysha Gene Therapies, Inc. 13G/A 9.99% 2y
Fourthstone LLC BRBS Blue Ridge Bankshares, Inc. 13G/A 8.42% 2y
Encompass Capital Advisors LLC OPAL OPAL Fuels Inc. 13G/A 9.8% 2y
Redmile Group, LLC STXS Stereotaxis, Inc. 13G/A 4.2% 2y
William Carlton Derrick WHLR Wheeler Real Estate Investment Trust, Inc. 13G/A 0.2% 2y
NEEDHAM INVESTMENT MANAGEMENT LLC AE Adams Resources & Energy Inc. 13G/A 5.38% 2y
T. Rowe Price Investment Management, Inc. EXE EXPAND ENERGY Corp 13G 6.7% 2y
Radcliffe Capital Management, L.P. VCXB 10X Capital Venture Acquisition Corp. III 13G/A 0% 2y
ARMISTICE CAPITAL, LLC PPBT Purple Biotech Ltd. 13G 9.99% 2y
Beutel, Goodman & Co Ltd. RBA Rb Global Inc. 13G/A 3.8% 2y
Judith A. Christian SGA Saga Communications Inc 13G/A 15.8% 2y
Omega Fund IV, L.P. REPL Replimune Group, Inc. 13G/A 5.5% 2y
HGC Investment Management Inc. USAR USA Rare Earth, Inc. 13G 9.7% 2y
CVI Investments, Inc. BDRX Biodexa Pharmaceuticals Plc 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ PCTY Paylocity Holding Corp 13G/A 15.2% 2y
Fourthstone LLC FCCO First Community Corp 13G/A 6.71% 2y
George Kurtz CRWD CrowdStrike Holdings, Inc. 13G/A 3.8% 2y
ALLIANCEBERNSTEIN L.P. MNSB MainStreet Bancshares, Inc. 13G/A 7.4% 2y
GLAZER CAPITAL, LLC EVGR Evergreen Corporation Class A Ordinary Share 13G/A 8.69% 2y
MACQUARIE GROUP LTD HGAS Global Gas Corp 13G/A 0% 2y
M3 Funds, LLC PDLB Ponce Financial Group, Inc. 13G/A 9.05% 2y
Peter Thiel PLTR Palantir Technologies Inc. 13G/A 7.1% 2y
PRICE T ROWE ASSOCIATES INC /MD/ PCOR Procore Technologies, Inc. 13G 6.3% 2y
Hydra LLC TRML Tourmaline Bio, Inc. Common Stock 13G/A 6.6% 2y
CONTINENTAL GENERAL INSURANCE CO RAIL FreightCar America, Inc. 13G/A 8.8% 2y
METEORA CAPITAL, LLC VHAQ Viveon Health Acquisition Corp. 13G/A 12.28% 2y
Deep Track Capital, LP VRDN Viridian Therapeutics, Inc.DE 13G/A 9.9% 2y
Dr. George H. Winn ELMD Electromed, Inc. 13G/A 6.4% 2y
Kynam Capital Management, LP VERA Vera Therapeutics, Inc. 13G/A 8.22% 2y
BIOTECHNOLOGY VALUE FUND L P GHRS GH Research PLC 13G/A 19.99% 2y
ARMISTICE CAPITAL, LLC SQFT Presidio Property Trust, Inc. 13G/A 9.99% 2y
SC US (TTGP), LTD. NU Nu Holdings Ltd. 13G/A 7% 2y
Coliseum Capital Management, LLC SONO Sonos Inc 13G/A 3.5% 2y
Clal Insurance Enterprises Holdings Ltd VRNT Verint Systems Inc 13G/A 2.3% 2y
Altai Capital Management, L.P. YTRA Yatra Online, Inc. 13G/A 8% 2y
Smith & Hood Holding Company, LLC FGBI First Guaranty Bancshares, Inc. 13D/A 8.52% 2y
COHEN & STEERS, INC. AKR Acadia Realty Trust 13G/A 16.56% 2y
HHLR ADVISORS, LTD. API Agora, Inc. 13G/A 5.1% 2y
ARMISTICE CAPITAL, LLC SRGA Surgalign Holdings, Inc. Common Stock 13G/A 4.99% 2y
Nantahala Capital Management, LLC THTX Theratechnologies Inc. Common 13G 5.8% 2y
Encompass Capital Advisors LLC RNGR Ranger Energy Services, Inc. 13G/A 6.2% 2y
FIR TREE CAPITAL MANAGEMENT LP MAQC Maquia Capital Acquisition Corporation Class A Common Stock 13G 6.35% 2y